Jenna Carroll Soper

Title: Jenna Carroll Soper: Innovator in ALS Treatment

Introduction

Jenna Carroll Soper is a prominent inventor based in Winchester, MA (US). She has made significant contributions to the field of medical research, particularly in the treatment of amyotrophic lateral sclerosis (ALS). Her innovative work has the potential to impact the lives of many individuals affected by this debilitating condition.

Latest Patents

Jenna holds a patent for the "Treatment of amyotrophic lateral sclerosis (ALS)." This patent involves AAVs encoding a SOD1 targeting polynucleotide, which may be utilized to treat ALS and offers delivery methods for spinal cord-related disorders, including ALS. This groundbreaking approach represents a significant advancement in ALS treatment options.

Career Highlights

Jenna is currently associated with Voyager Therapeutics, Inc., where she continues to develop innovative therapies for neurological diseases. Her dedication to research and development has positioned her as a key figure in the fight against ALS.

Collaborations

Jenna collaborates with esteemed colleagues, including Dinah Wen-Yee Sah and Holger Patzke. These partnerships enhance her research efforts and contribute to the advancement of ALS treatment methodologies.

Conclusion

Jenna Carroll Soper's work in ALS treatment exemplifies the spirit of innovation in medical research. Her contributions are paving the way for new therapeutic approaches that could change the landscape of ALS treatment.